J. Safra Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.8K Sell
1,049
-16,992
-94% -$923K ﹤0.01% 274
2026
Q1
$1.13M Buy
18,041
+2,637
+17% +$211K 0.06% 88
2025
Q4
$1.47M Buy
15,404
+3,598
+30% +$353K 0.08% 74
2025
Q3
$1.15M Buy
11,806
+4,057
+52% +$420K 0.07% 64
2025
Q2
$832K Buy
7,749
+197
+3% +$19.9K 0.06% 72
2025
Q1
$762K Buy
7,552
+2,686
+55% +$270K 0.06% 56
2024
Q4
$436K Buy
4,866
+1,943
+66% +$171K 0.04% 64
2024
Q3
$244K Buy
2,923
+1,269
+77% +$100K 0.02% 58
2024
Q2
$127K Buy
1,654
+1,426
+625% +$104K 0.01% 80
2024
Q1
$15.6K Buy
+228
New +$14.7K ﹤0.01% 128
2022
Q2
Sell
-41
Closed 42
2022
Q1
$0 Buy
+41
New +$1.78K ﹤0.01% 55

Other funds holding BSX

J. Safra Asset Management's BSX Position: Q2 2026 in Review

J. Safra Asset Management reduced its Boston Scientific (BSX) stake by 94% in Q2 2026, selling an estimated $923K and leaving 1,049 shares worth $44.8K. The position accounts for ﹤0.01% of the portfolio, ranked #274.

J. Safra Asset Management first reported a position in BSX in Q1 2022 and has held it in 11 quarters since. The position peaked at $1.47M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • J. Safra Asset Management held 1,049 shares of Boston Scientific worth $44.8K as of Q2 2026.
  • J. Safra Asset Management sold 16,992 Boston Scientific shares in Q2 2026, an estimated $923K.
  • Boston Scientific made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #274 holding.
  • J. Safra Asset Management first reported a position in Boston Scientific in Q1 2022 and has held it in 11 quarters since.
  • J. Safra Asset Management's Boston Scientific position peaked at $1.47M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.